Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of membership benefits, join or renew today!
Salim Hayek, MD, a cardiovascular specialist in cardio-oncology from the UTMB Health is joined by Amelia Langston, MD, a hematology and medical oncology specialist from Emory University to discuss their new AHA scientific statement on the cardiovascular management of patients undergoing hematopoietic stem cell transplantation (HSCT). They review the phases of HCST, the incidence of cardiovascular complications, long-term management, and the significance of survivorship post-transplant.
Recommended Videos
Secondary Prevention, Anticoagulants, and
Cervical Artery Dissection in Adults Statement: Overview and Diagnosing
The Risk of Recurrent Cervical Artery Dissection in Adults
Distinguishing Between Opioid Overdose and Cardiac Arrest
Overview of the Opioid-Associated Out-of-Hospital Cardiac Arrest Statement
Loading...
Save Video
Video is not available. Please check the URL.